American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C

Lead Story: Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C

Tuesday 12th July 2022

Discover how laws in 16 states and Washington D.C. are expanding access to opioid use disorder medications on 'Addiction Medicine Unpacked'.
7 minutes
Informative
Educational
Eye-opening
Thought-provoking
Engaging

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Breaking Down Barriers: Expanding Access to Opioid Use Disorder Medications

The policies that appear to expand MOUD access fall within six policy domains: expanding the availability of waivered buprenorphine providers, expanding MOUD awareness, criminal justice, licensed SUD facilities, insurers, and hospitals.
Ever wondered how laws can shape the availability of life-saving medications for opioid use disorder (OUD)? This episode of 'Addiction Medicine Unpacked' dives into a comprehensive legal analysis covering 16 states and Washington D.C. The study, published in The American Journal of Drug and Alcohol Abuse, identifies six key policy areas that help expand access to medications like buprenorphine.
From increasing the number of waivered providers to boosting MOUD awareness, this episode highlights the significant strides some states are making while others lag behind. But that's not all. You'll also hear about intriguing studies on addiction medicine, including the potential risks of dementia after quitting smoking and the benefits of combining bupropion and naltrexone for those battling both opioid and stimulant use.
The episode even touches on the complex relationship between police contracts for drug-related crimes and future arrests, incarceration, and overdoses. Whether you're a healthcare professional, a policy-maker, or someone affected by addiction, this episode offers valuable insights into the evolving landscape of addiction treatment and prevention strategies.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.